Massachusetts Financial Services
JNCE

Massachusetts Financial Services’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Massachusetts Financial Services’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-156,631
Closed -$1.08M – 909
2020
Q2 		$1.08M Sell
156,631
-126,324
-45% -$681K ﹤0.01% 734
2020
Q1 		$1.34M Buy
+282,955
New +$1.63M ﹤0.01% 715

Other funds holding JNCE

TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Massachusetts Financial Services's JNCE Position: Q3 2020 in Review

Massachusetts Financial Services sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q3 2020, closing a stake of 156,631 shares — an estimated $1.08M sold.

Massachusetts Financial Services first reported a position in JNCE in Q1 2020 and held it in 2 quarters. The position peaked at $1.34M in Q1 2020. 102 funds tracked by Wall St. Rank hold JNCE as of Q3 2020.

  • Massachusetts Financial Services reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Massachusetts Financial Services sold 156,631 Jounce Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $1.08M.
  • Massachusetts Financial Services first reported a position in Jounce Therapeutics, Inc. Common Stock in Q1 2020 and held it in 2 quarters.
  • Massachusetts Financial Services's Jounce Therapeutics, Inc. Common Stock position peaked at $1.34M in Q1 2020.
  • 102 funds tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q3 2020.

Based on Massachusetts Financial Services's 13F filing for Q3 2020, filed 12 Nov 2020.